Assessing and responding to stress related to pulmonary function testing in cystic fibrosis through quality improvement.
behavioral health
procedural anxiety
stress management
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
05
07
2019
accepted:
18
01
2020
pubmed:
11
2
2020
medline:
12
11
2020
entrez:
11
2
2020
Statut:
ppublish
Résumé
Pulmonary function tests (PFTs) are performed routinely to evaluate lung function in patients with cystic fibrosis (CF). Staff at the Cincinnati Children's Hospital Medical Center CF Center observed stress in patients before PFTs. An interdisciplinary quality improvement (QI) team was assembled to address this clinical issue. The Plan-Do-Study-Act method of QI was used to investigate feasibility of assessing stress and offering brief interventions to reduce stress before PFTs. Interventions included listening to music, covering the PFT screen, or doing breathing meditation before PFTs. Patients rated stress levels on a 1 to 5 Likert scale before and after testing. Of 75 patient encounters, interventions were trialed in 20. Fifteen patients who tried an intervention reported wanting to use the intervention again (five encounters had missing data); patients reported that the intervention benefited performance on PFTs in eight encounters (40%). The average pre-PFT stress rating for encounters that trialed an intervention was 2.1 and post-PFT rating was 2.0. Average stress pre-PFT and post-PFT ratings were 1.7 and 1.6 respectively, for encounters that did not trial an intervention. Median length of PFT encounter was 15 minutes regardless of whether intervention was trialed. Some patients with CF utilized interventions, while many opted out. This QI effort identified feasible outpatient clinic interventions that did not negatively impact clinic flow. Finding ways to reduce stress associated with PFTs could have a meaningful impact on patient performance and emotional well-being for a subset of patients.
Sections du résumé
BACKGROUND
Pulmonary function tests (PFTs) are performed routinely to evaluate lung function in patients with cystic fibrosis (CF). Staff at the Cincinnati Children's Hospital Medical Center CF Center observed stress in patients before PFTs. An interdisciplinary quality improvement (QI) team was assembled to address this clinical issue.
METHODS
The Plan-Do-Study-Act method of QI was used to investigate feasibility of assessing stress and offering brief interventions to reduce stress before PFTs. Interventions included listening to music, covering the PFT screen, or doing breathing meditation before PFTs. Patients rated stress levels on a 1 to 5 Likert scale before and after testing.
RESULTS
Of 75 patient encounters, interventions were trialed in 20. Fifteen patients who tried an intervention reported wanting to use the intervention again (five encounters had missing data); patients reported that the intervention benefited performance on PFTs in eight encounters (40%). The average pre-PFT stress rating for encounters that trialed an intervention was 2.1 and post-PFT rating was 2.0. Average stress pre-PFT and post-PFT ratings were 1.7 and 1.6 respectively, for encounters that did not trial an intervention. Median length of PFT encounter was 15 minutes regardless of whether intervention was trialed.
CONCLUSION
Some patients with CF utilized interventions, while many opted out. This QI effort identified feasible outpatient clinic interventions that did not negatively impact clinic flow. Finding ways to reduce stress associated with PFTs could have a meaningful impact on patient performance and emotional well-being for a subset of patients.
Identifiants
pubmed: 32040891
doi: 10.1002/ppul.24673
pmc: PMC8864550
mid: NIHMS1552825
doi:
Types de publication
Controlled Clinical Trial
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1139-1146Subventions
Organisme : NHLBI NIH HHS
ID : T35 HL113229
Pays : United States
Organisme : NIH HHS
ID : 5T35HL113229-07
Pays : United States
Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Pediatr Pulmonol. 2020 May;55(5):1139-1146
pubmed: 32040891
Thorax. 2006 Jan;61(1):80-5
pubmed: 16244089
J Cyst Fibros. 2017 May;16(3):318-326
pubmed: 28117136
BMJ Qual Saf. 2014 Apr;23(4):290-8
pubmed: 24025320
Am J Respir Crit Care Med. 2017 Dec 1;196(11):1463-1472
pubmed: 29192835
Am J Respir Crit Care Med. 2009 Nov 1;180(9):802-8
pubmed: 19729669
J Cyst Fibros. 2018 Mar;17(2):153-178
pubmed: 29506920
Child Care Health Dev. 2009 Jul;35(4):462-8
pubmed: 18991968
Chest. 2002 Jan;121(1):64-72
pubmed: 11796433
Psychiatr Clin North Am. 2014 Dec;37(4):455-87
pubmed: 25455061
Curr Opin Pulm Med. 2016 Mar;22(2):187-91
pubmed: 26814144
J Paediatr Child Health. 2006 Oct;42(10):596-600
pubmed: 16972965
J Cyst Fibros. 2009 Mar;8(2):91-6
pubmed: 18952504